product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
MSH2 (D24B5) XP® Rabbit mAb
catalog :
2017
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D24B5
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig s3
Ah Koon L, Lesage D, Lemadre E, Souissi I, Fagard R, Varin Blank N, et al. Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells. J Cell Mol Med. 2016;20:1956-65 pubmed publisher
  • western blot; human; 1:1000; fig 1g
Masuda Y, Takahashi H, Sato S, Tomomori Sato C, Saraf A, Washburn M, et al. TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. Nat Commun. 2015;6:7299 pubmed publisher
  • immunohistochemistry - paraffin section; human; 1:200
  • western blot; human
Kucherlapati M, Esfahani S, Habibollahi P, Wang J, Still E, Bronson R, et al. Genotype directed therapy in murine mismatch repair deficient tumors. PLoS ONE. 2013;8:e68817 pubmed publisher
Parisi T, Bronson R, Lees J. Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer. Oncogene. 2015;34:5890-9 pubmed publisher
product information
SKU :
2017P
Product-Name :
MSH2 (D24B5) XP® Rabbit mAb
Size :
40 ul
Price-(USD) :
135 USD
Species-x-Reactivity :
H, M
Applications :
Flow cytometry
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
100
Host :
Rabbit
Target :
Msh2
Primary-Protein :
MSH2
Alt-Names :
COCA1,DNA mismatch repair protein Msh2,FCC1,HNPCC,HNPCC1,LCFS2,MSH2,MutS protein homolog 2,hMSH2,mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.